|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7370 EUR | +1.24% |
|
-3.28% | -30.34% |
| 01/07 | Amoéba Receives Marketing Authorization For Biofungicide AXPERA In France | CI |
| 30/06 | Amoéba gains from marketing authorization in France |  |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.761 | 0.9 | 0.936 |
| Spread/Res. | -3.15% | -18.11% | -21.26% |
| Spread/Supp. | +3.51% | +17.17% | +13.91% |
| Support | 0.712 | 0.629 | 0.647 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ALMIB Stock
- Charts Amoéba
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
